News & Views
Celerion Establishes Business Presence in Singapore and Appoints Dr Chew Lan Chong as Executive Director
Sep 15 2014
Celerion is pleased to announce the expansion of a formal business presence in Singapore. Heading up the new operations in Singapore is Dr Chew Lan Chong, MBBS, MRCS, MSc as Executive Director, Medical Research. Dr Chong brings 10 years of direct operational experience leading clinical pharmacology units.
Dr Chong will lead Celerion’s business operations in Singapore, provide medical and scientific expertise and collaborate with partner early clinical research units to conduct complex early clinical pharmacology studies to the highest global standards.
“We are delighted to continue to build a strong footprint in Asia with our new office in Singapore, headed up by Chew Lan,” said Frederick Pritchard PhD Vice President of Global Drug Development at Celerion. “The continued expansion in Asia demonstrates Celerion’s commitment to providing clients innovative solutions to conduct patient studies.”
Dr Chong brings to Celerion a wealth of operational experience, having conducted over 130 early clinical studies at organisations including Pfizer and Lilly in Singapore. Dr Chong completed postgraduate medical training through The Royal College of Surgeons in Edinburgh. She received her medical degree from Singapore National University. In 2011, she complemented her medical training and industry experience by earning a Master’s degree in Experimental Therapeutics from The University of Oxford.
Digital Edition
International Labmate Buyers' Guide 2024/25
June 2024
Buyers' Guide featuring: Product Listings & Manufacturers Directory Chromatography Articles - Enhancing HPLC Field Service with fast-response, non-invasive flowmeters - Digital transformatio...
View all digital editions
Events
Jul 20 2024 Denver, CO, USA
Jul 21 2024 Cape Town, South Africa
Jul 28 2024 San Diego, CA USA
Jul 30 2024 Jakarta, Indonesia
Jul 31 2024 Chengdu, China